TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Sheldon Koenig
Esperion Partner Otsuka Launches NEXLETOL® in Japan for the Treatment of Hypercholesterolemia

Esperion announced that its partner Otsuka launched NEXLETOL in Japan, receiving a $90 million payment for the cardiovascular prevention drug's national health insurance price listing and market entry.

Insights
GOOGL   positive

AI is strengthening core search offerings, revenue grew 16% to over $100 billion quarterly, Google Cloud revenue surged 34%, and AI is improving search monetization without disruption


ESPR   positive

Received significant milestone payment, expanded market presence in Japan's third-largest cardiovascular prevention market